Font Size: a A A

Relationship Between Serum Hepcidin Levels And The Iron Metabolism In Patients With Hemodialysis

Posted on:2012-09-28Degree:MasterType:Thesis
Country:ChinaCandidate:Y ZhangFull Text:PDF
GTID:2214330362952107Subject:Internal Medicine
Abstract/Summary:PDF Full Text Request
Objective To investigate the serum Hepcidin level and the relationship with iron metabolism in maintenance hemodialysis patients (MHD) and non-dialysis patients with end-stage renal disease (ESRD). Methods Thirty MHD patients and thirty non-dialysis patients with ESRD were included in our study, and thirty normal healthy people for contrast. Serum Hepcidin and total iron-binding capacity (TIBC) were measured by ELISA, SI, FER, TRF and other indicators were measured routinely and compared. Results①Serum Hepcidin level was significantly higher in MHD patients and non-dialysis patients with ESRD than that in healthy control group (P<0.01).②Serum Hepcidin of MHD patients was higher than in non-dialysis patients with ESRD (P<0.05).③Pearson correlation analysis revealed serum Hepcidin was positively correlated with Scr (r=0.969), hs-CRP (r=0.515), iPTH (r=0.290), FER (r=0.286), (p<0.05); while negatively with HGB(r=-0.543), RBC(r=-0.540), eGFR(r=-0.534), HCT(r=-0.466), TRF(r=-0.362),SI(R=-0.360),TIBC(r=-0.285),ALB(r= -0.248),TIBC(r=-0.285), ALB(r=-0.248), TP(r=-0.224), (P<0.05).④Multiple regression analysis showed RBC, HGB, hs-CRP, FER, TRF, TIBC were closely associated with the level of serum Hepcidin in non-dialysis patients with ESRD; While RBC, HGB, eGFR, FER, TIBC were closely associated with the level of serum Hepcidin in MHD patients.⑤In non-dialysis patients with ESRD, the area of serum hepcidin under the ROC curve is 86.3%.The sensitivity and specificity were 76.7% and 99.1%, respectively. In maintenance hemodialysis patients, the area of serum hepcidin under the ROC curve is 84.6%. The sensitivity and specificity were 73.0% and 99.8%, respectively. Conclusions①Serum Hepcidin level was significantly higher in MHD patients and non-dialysis patients with ESRD than that in healthy control group.②.Serum Hepcidin of MHD patients was higher than in non-dialysis patients with ESRD.③These findings suggest that increased Hepcidin may contribute to abnormal iron regulation and erythropoiesis.④Serum Hepcidin on the diagnosis of functional iron deficiency was high sensitivity and specificity and may be a novel serum marker of iron status.
Keywords/Search Tags:hepcidin, aintenance hemodialysis, non-dialysis with end-stage renal disease, iron regulation
PDF Full Text Request
Related items